1. Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial. (January 2017) Authors: Rouzier, Roman; Gouy, Sébastien; Selle, Frédéric; Lambaudie, Eric; Floquet, Anne; Fourchotte, Virginie; Pomel, Christophe; Colombo, Pierre-Emmanuel; Kalbacher, Elsa; Martin-Francoise, Sandrine; Fauvet, Raffaele; Follana, Philippe; Lesoin, Anne; Lecuru, Fabrice; Ghazi, Youssef; Dupin, Julien; Cher... Journal: European journal of cancer Issue: Volume 70(2017) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database. (November 2022) Authors: Tredan, Olivier; Laurent, Marie; Gilberg, Melina; Ghorbal, Rim; Vainchtock, Alexandre; Lortet-Tieulent, Joannie; Prodel, Martin; Dupin, Julien Journal: Cancer informatics Issue: Volume 21(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study. (November 2020) Authors: Coudert, Bruno; Pierga, Jean-Yves; Mouret-Reynier, Marie-Ange; Kerrou, Kaldoun; Ferrero, Jean-Marc; Petit, Thierry; Du, Fanny Le; Dupré, Pierre-François; Bachelot, Thomas; Gabelle, Philippe; Chauvet, Marie-Pierre; Coeffic, David; Barbe, Catherine; Prevost, Jean-Briac; Paintaud, Gilles; Thibault, ... Journal: EClinicalMedicine Issue: Volume 28(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗